ARCHIVES

AZURE Trial: Zoledronic Acid Didn’t Improve DFS In Stage II/III

This article is from The Cancer Letter archive.

Vol. 33 No. 12 | December 31, 2010

Download PDF Visit The Full Archive

Related Articles

Funding opportunities listed.

June 25, 2004

NCI Advisory Group, Other Cancer Meetings

February 28, 1986

Shingleton To Retire As Director Of Duke Comprehensive Center

July 10, 1981

NCI to Support Research and Development Of Image Guided Therapy for Prostate Cancer

July 16, 1999

In Brief: Brady Wins ACRO Gold Medal; Society Elects New Fellows; Calabresi Honored

July 5, 1996

The Cancer Letter Wins Awards (12-page issue).

June 13, 2003